Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

92.92 -0.01 (-0.01%)
Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
AI Revolutionizes Drug Shelf-Life: Optimized Stability Models Promise Safer, More Effective Medicines
The pharmaceutical industry is on the cusp of a profound transformation, driven by the integration of data science and Artificial Intelligence (AI) into drug formulation stability models. This... 
Via TokenRing AI
Topics Artificial Intelligence Economy Product Recall
News headline image
AI and Digital Twins Ignite a New Era of Accelerated Drug Discovery and Development
The pharmaceutical industry is on the cusp of a profound transformation, driven by the synergistic power of artificial intelligence (AI) and digital twins. These cutting-edge technologies are rapidly... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
The pharmaceutical and biotechnology sectors are experiencing a period of significant dynamism and robust growth as of November 2025, fueled by a confluence of scientific advancements, a resurgence in... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Merck Swoops In On Buyout Bonanza With A $9.2 Billion Cidara Therapeutics Deal ↗
The company is getting deeper into the antiviral space, buying a company working on a long-acting drug to protect against flu. 
Via Investor's Business Daily
News headline image
Merck Makes Big Bet On Flu Protection With Cidara Buyout ↗
Merck (NYSE: MRK) to acquire Cidara (NASDAQ: CDTX) for $9.2 billion, diversifying its portfolio with CD388. 
Via Benzinga
News headline image
Merck To Buy Cidara In $9.2B Deal To Strengthen Antiviral Portfolio ↗
With the new deal, Merck would gain access to CD388, currently in late-stage development, and designed to prevent influenza infection in individuals at higher risk of influenza complications. 
Via Stocktwits
Topics Intellectual Property
News headline image
Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
From Merck & Co., Inc.
Via Business Wire
Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium ↗
Via Stocktwits
News headline image
Merck to Participate in the Jefferies Global Healthcare Conference in London
From Merck & Co., Inc.
Via Business Wire
News headline image
Tech Sector Tremors: Is the AI Bubble Deflating, and What's Next for the Market?
As of mid-November 2025, a palpable unease has settled over the technology sector, long the darling of investors and the primary engine of market growth. After a period of unprecedented outperformance,... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead? ↗
Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Is the Schwab U.S. Dividend Equity ETF the "Ultimate Retirement Fund" for Investors? ↗
A $10,000 investment in this diversified fund at its 2011 inception would be worth $51,000 today. 
Via The Motley Fool
Topics ETFs Economy Retirement
News headline image
The Data Drought of 2024: Recalling the Urgent Call for November Jobs and CPI Figures Post-Shutdown
Washington D.C. – November 12, 2025 – Looking back from today, the critical period following a hypothetical, yet highly plausible, U.S. government shutdown in late 2024 served as a stark reminder of... 
Via MarketMinute
Topics Economy
News headline image
Nasdaq Stumbles: Tech Sector Faces Reality Check Amid Valuation Concerns and Sector Rotation
The Nasdaq Composite (NASDAQ: IXIC) experienced back-to-back losses on November 11 and 12, 2025, signaling a significant recalibration in the financial markets. This downturn, primarily driven by... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Dow Jones Soars to Unprecedented Heights as Market Cheers Government Shutdown Resolution
New York, NY – November 12, 2025 – The Dow Jones Industrial Average (DJIA) has shattered previous records, closing at an all-time high of 48,254.82 today, marking a significant milestone for the... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Dow Soars Past 48,000 as Gold and Silver Shine in a Market of Paradox
New York, NY – November 12, 2025 – In a remarkable display of market resilience and underlying tension, the Dow Jones Industrial Average (DJIA) has surged past the 48,000-point threshold, closing at an... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Unprecedented Market Anomaly: Gold and Silver Soar as Dow Breaches 48,000 Amidst Inflationary Fears and Geopolitical Tensions
The financial markets are currently exhibiting an extraordinary and complex phenomenon: both traditional safe-haven assets, gold and silver, are experiencing robust rallies, while the Dow Jones... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
2 Strong Healthcare Stock Picks for Value Investors ↗
Value-driven plays abound in the top healthcare stocks. 
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Stocks Down 13% and 34% to Buy Right Now ↗
It's been a year to forget for these two companies, but brighter days are ahead. 
Via The Motley Fool
Topics Intellectual Property World Trade
News headline image
Dow Breaches 48,000 Milestone Amidst Government Shutdown Resolution Hopes, S&P 500 and Nasdaq Lag
The Dow Jones Industrial Average (DJIA) made history on Wednesday, November 12, 2025, surging past the 48,000-point mark for the first time ever, gaining nearly 380 points. This significant rally was... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Google To Run Ohio Data Centers On Solar Power From TotalEnergies ↗
TotalEnergies and Google have signed a 15-year PPA for renewable electricity. The deal aligns with both companies' goals. 
Via Benzinga
News headline image
Dow Jones Industrial Average Soars to Record High: A Nuanced Signal for the Economy
NEW YORK, NY – November 11, 2025 – The Dow Jones Industrial Average (DJIA) has reached an unprecedented milestone today, soaring to a new all-time high of 47,927.96, a robust gain of 559.33 points... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Dow Jones Industrial Average Soars to New All-Time High Amidst Shifting Market Dynamics
New York, NY – November 11, 2025 – The Dow Jones Industrial Average (DJIA) has today surged to an unprecedented all-time high, pushing past significant milestones and reinforcing a complex, yet largely... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
News headline image
What's going on in today's session: S&P500 movers ↗
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
News headline image
Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market? ↗
Three large pharmaceutical makers are jockeying for position in the rapidly expanding market for GLP-1 drugs. 
Via The Motley Fool
News headline image
Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds
New York, NY – November 10, 2025 – The S&P 500 Healthcare sector presented a mixed picture today, with the broader index showing a modest uptick while significant segments, particularly health insurers... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Cliff Asness: The Stock Market is Expensive, Not a Bubble – A Call for Rationality in a Less Efficient Market
New York, NY – November 10, 2025 – In a financial landscape often characterized by extremes, Cliff Asness, the influential co-founder of AQR Capital Management, offers a nuanced yet stark assessment of... 
Via MarketMinute
Topics Economy
News headline image
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Adults with Heterozygous Familial Hypercholesterolemia (HeFH) in Phase 3 CORALreef HeFH Trial
From Merck & Co., Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.